These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 120487)
1. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs. Uemiya M; Saiki I; Kusama T; Azuma I; Yamamura Y Microbiol Immunol; 1979; 23(8):821-3. PubMed ID: 120487 [No Abstract] [Full Text] [Related]
2. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds. Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234 [TBL] [Abstract][Full Text] [Related]
3. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine. Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117 [No Abstract] [Full Text] [Related]
4. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs. Uemiya M; Sugimura K; Kusama T; Saiki I; Yamawaki M; Azuma I; Yamamura Y Infect Immun; 1979 Apr; 24(1):83-9. PubMed ID: 313372 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine. Yamamura Y; Azuma I; Sugimura K; Yamawaki M; Uemiya M Gan; 1976 Dec; 67(6):867-77. PubMed ID: 828599 [TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2. Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716 [No Abstract] [Full Text] [Related]
7. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant activity of nocardomycoloyl derivatives of N-acetylmuramyldipeptide in mice and guinea pigs. Saiki I; Uemiya M; Kusama T; Yamamura Y; Azuma I Microbiol Immunol; 1980; 24(3):265-9. PubMed ID: 6968020 [No Abstract] [Full Text] [Related]
9. Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Azuma I; Kamisango KI; Saiki I; Tanio Y; Kobayashi S; Yamamura Y Infect Immun; 1980 Sep; 29(3):1193-6. PubMed ID: 7429634 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant and antitumor activities of quinonyl-N-acetylmuramyldipeptides. Azuma I; Yamawaki M; Uemiya M; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Imada I; Yamamura Y Gan; 1979 Dec; 70(6):847-8. PubMed ID: 535688 [No Abstract] [Full Text] [Related]
11. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido- 1,2,3,5-tetradeoxy-1,5-imino-D-glucitol-3-yl)-D-lactoyl]- L-alanyl-D-isoglutamine. Ishida H; Kitagawa M; Kiso M; Hasegawa A; Azuma I Carbohydr Res; 1990 Dec; 208():267-72. PubMed ID: 2085813 [No Abstract] [Full Text] [Related]
12. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil. Carelli C; Audibert F; Chedid L Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and immunoadjuvant activities of muramoyl-L-alanyl-D-isoglutamine and some carbohydrate analogs. Kiso M; Kaneda Y; Okumura H; Hasegawa A; Azuma I; Yamamura Y Carbohydr Res; 1980 Feb; 79(1):C17-9. PubMed ID: 7357566 [No Abstract] [Full Text] [Related]
14. Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs. Saiki I; Tanio Y; Yamawaki M; Uemiya M; Kobayashi S; Fukuda T; Yukimasa H; Yamamura Y; Azuma I Infect Immun; 1981 Jan; 31(1):114-21. PubMed ID: 6971259 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities. Hasegawa A; Kaneda Y; Goh Y; Nishibori K; Kiso M; Azuma I Carbohydr Res; 1981 Aug; 94(2):143-63. PubMed ID: 7273036 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of some lipophilic derivatives of 1-thio-muramoyl-L-alanyl-D-isoglutamine. Hasegawa A; Seki E; Hioki Y; Kiso M; Azuma I Carbohydr Res; 1984 Aug; 131(1):61-9. PubMed ID: 6488202 [TBL] [Abstract][Full Text] [Related]
17. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP). Adam A; Souvannavong V; Lederer E Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370 [No Abstract] [Full Text] [Related]
18. Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Azuma I; Okumura H; Saiki I; Tanio Y; Kiso M; Hasegawa A; Yamamura Y Infect Immun; 1981 Jun; 32(3):1305-8. PubMed ID: 7251169 [TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde. Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of N-acetyl-6-amino- and -6-(acylamino)-6-deoxymuramoyl dipeptides, and their immunoadjuvant activities. Hasegawa A; Okumura H; Kiso M; Azuma I; Yamamura Y Carbohydr Res; 1980 Feb; 79(1):C20-3. PubMed ID: 7357567 [No Abstract] [Full Text] [Related] [Next] [New Search]